ArticleFrontiers in oncology2025

Long-term survival after ALK-TKI resistance through immunotherapy combined with chemotherapy in ALK-positive non-small cell lung cancer: a case report.

Caihong Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.